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Summary. Prolact in  cell a d e n o m a  is the mos t  f requent ly  
found  lesion in surgically r e m o v e d  pituitaries o f  pat ients  
with hyperpro lac t inemia .  However ,  in several instances,  
ins tead o f  prolact in  cell a d e n o m a ,  o the r  lesions are 
encoun te r ed  by morpho log ica l  investigation.  We repor t  
here  the  morpho log ica l  findings in a pat ient  with 
hyperp ro lac t inemia  who  unde rwen t  t ranssphenoidal  
p i tu i tary  surgery for  suspected  prolact in  cell adenoma .  
A morpho log ica l  diagnosis o f  t u m o r  could no t  be  
conf i rmed  and massive diffuse prolact in  cell hyperplas ia  
was identified.  The  aim of  this publ icat ion is to describe 
the  lesion by histology, immunocy tochemis t ry ,  e lect ron 
microscopy,  and in situ hybr id iza t ion  and to call a t ten-  
t ion to  p r imary  prolact in  cell hyperplas ia  which can 
mimic prolact in  cell a d e n o m a .  
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The  mos t  c o m m o n  finding in pat ients  with hyperpro lac-  
t inemia  is a prolact in  cell a d e n o m a  of  the  pituitary. 
E leva ted  se rum prolact in  levels may, however ,  be 
encoun te r ed  in a n u m b e r  of  clinical s tates such as 
pregnancy,  d rug  therapy,  endocr ine  diseases, notably, 
hypo thyro id i sm,  and pi tu i tary  stalk compress ion  or  
d isrupt ion [3, 5, 10, 13, 18, 20, 22, 23, 26, 28, 29]. In  the  
present  repor t  we descr ibe unusual  pa thologica l  findings 
in a pat ient  with hyperpro lac t inemia  who  unde rwen t  
t ranssphenoida l  p i tu i tary  surgery for  suspected  prolact in  
cell a d e n o m a .  
months. Her last menstrual period had been about 6 months prior 
to admission. There was no associated galactorrhea. The patient 
used no oral contraceptives or other medications. 
Physical examination revealed a short statured woman in good 
health. Systemic examination including neurological assessment 
was within normal limits. There was no clinical evidence of thyroid 
disease or galactorrhea. 
CT and MR scans of the head showed increased tissue on the 
left side in the adenohypophysis. The posterior gland appeared to 
be normally situated with no radiographic abnormalities. 
The significant finding on biochemical studies was a serum 
prolactin level of 256 ~g/1 (normal range 0-20) with an exaggerated 
response to intravenous thyrotropin-releasing hormone (TRH) 
testing with a baseline of 199 ~tg/1 increasing to 1101 ~g/1. The 
baseline thyroid-stimulating hormone (TSH) was 6.8 mUff (normal 
range 0.3-3.5) which increased onTRH administration to a level of 
48.5 mU/1. The serum thyroxine level was 93 nmol/1 (normal range 
60-155) with the T3 resin uptake of 0.40 (normal range 0.25-0.35) 
and a free thyroxine index of 0.37. The total T3 level was 1.9 nmol/1 
(normal range 1.2-3.4). The serum levels of growth hormone 
(GH), follicle-stimulating hormone (FSH), luteinizing hormone 
(LH), adrenocorticotropic hormone (ACTH), cortisol and testos- 
terone were within normal limits. 
One week prior to surgery, the patient had a menstrual period. 
Transsphenoidal exploration revealed no discrete adenoma. 
Except for a transient diabetes insipidus, the patient had an 
uneventful postoperative course. On the 1st, 2nd and 3rd post- 
operative days, serum prolactin levels remained at about double 
the upper limit of normal at 57, 52, and 50 ~tg/1; the TRH test 
showed a baseline of 50 ag/1 with a peak which was very high 
around 170 ~g/1. The patient also received 0.075 mg oral thyroxine 
daily for 2 weeks and 0.15 mg for another 2 weeks. This resulted in 
lowering of the serum TSH levels but there was persistence of the 
high serum prolactin levels in the postoperative range described 
above. A detailed workup to look for an ectopic source for 
prolactin release including CT scans of abdomen, lung, pelvis and 
neck was negative. 
Case report 
This 38-year-old woman with two children aged 11 and 17 years was 
investigated for headaches and irregular menses. The patient had 
had irregular menstruation in the preceding 11 years. About 4 years 
prior to this admission, there was a period of amenorrhea lasting 9 
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Pathology 
M e ~ o ~  
Pieces of surgically resected tissue were fixed in 10% buffered 
formalin and embedded in paraffin. Sections, 4-6 ~tm thick, were 
stained with hematoxylin and eosin, Gordon-Sweet silver and the 
PAS methods. For immunocytochemistry, the avidin-biotin-perox- 
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idase complex technique was applied as described elsewhere [2, 7, 
8]. The following antibodies were used: anti-humanGH, anti- 
hPRL, anti-hACTH, anti-f3 hLH, anti-hFSH, anti-hTSH, and 
cr the dilutions and sources are as described elsewhere 
[12]. For electron microscopy, tissues were fixed in 2.5% glutaral- 
dehyde, postfixed in 1% osmium tetroxide, dehydrated in ethanol, 
and embedded in Epon-Araldite mixture. Ultrathin sections were 
stained with lead citrate and uranyl acetate and studied with a 
Philips 410 LS electron microscope. 
For the demonstration of GH and prolactin mRNA, in situ 
hybridization was used as described elsewhere [12]. 
Morphological findings 
The surgical specimen revealed sizeable fragments of 
non-tumorous adenohypophysis composed predomi- 
nantly of chromophobic cells interspersed with acido- 
philic and scattered basophilic PAS-positive cells. The 
Gordon-Sweet silver stain revealed significant distortion 
of the reticulin network. Although the acinar architec- 
ture was still evident, marked enlargement of acini and 
even fragmentation of the reticulin fibers were noted 
(Fig. 1). By immunostaining, cells positive for GH were 
present throughout the specimen; their numbers, how- 
ever, were markedly reduced (Fig. 2).The large majority 
of cells were immunoreactive for prolactin with a 
predominant Golgi-pattern of immunoreactivity, al- 
though a small contingent of larger, densely granulated 
cells were also positive for prolactin (Fig. 3). A varying 
number of scattered cells were positive for ACTH, TSH, 
FSH, LH,  and c~-subunit. 
Electron microscopy revealed non-tumorous adeno- 
phypophysis with the large majority of cells representing 
prolactin cells with extensively developed rough endo- 
plasmic reticulum and Golgi apparatus and variable 
granularity. Granule extrusions were mainly orthotopic. 
Corticotrophs, thyrotrophs and gonadotrophs were also 
encountered. Extracellular endocrine amyloid was 
found. 
In situ hybridization revealed a large number of cells 
showing strong labelling with the prolactin probe 
(Fig. 4). Labelling for GH was in the normal range 
(Fig. 5). 
Fig. 1. Gordon-Sweet silver stain demonstrating distortion of 
reticulin fiber network with enlargement of acini, x 66 
Fig. 2. Immunostaining for growth hormonal (GH) reveals scat- 
tered immunoreactive cells (arrow). x 115 
Discussion 
This unusual adenohypophysial lesion represents a 
massive diffuse hyperplasia of prolactin cells. The 
morphological study of a large number of human 
pituitaries has provided conclusive evidence that hyper- 
plasia of various adenohypophysial cell types exists [1, 6, 
11, 19, 24]. The investigation of hyperplasia in surgically 
removed pituitary specimens may be greatly hindered by 
several factors including variations in the regional 
distribution of some cell types and the often fragmented 
nature and poor quality of some surgical specimens. In 
the present case, the criteria for establishing the diag- 
nosis of hyperplasia included lack of a visible discrete 
pituitary adenoma at surgery, and by histology, a diffuse 
proliferation of immunoreactive prolactin cells, a dif- 
Fig. 3. Immunostaining for prolactin reveals positive immuno- 
reactivity in many cells with a Golgi pattern of staining (arrows). 
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Fig. 4. a Strong expression of prolactin mRNA is demonstrated by in situ hybridization, b negative control, a, b • 225 
Fig. 5. Normal labelling for GH is demonstrated by in situ 
hybridization. • 115 
fusely abnormal reticulin pattern suggesting a cellular 
overgrowth and fusion of adjacent acini, and an admix- 
ture of cytologically normal secretory cells of other 
hormonal types. 
While the most common cause of hyperprolactinemia 
is a prolactin cell adenoma, elevated serum prolactin 
levels may be encountered in a number of situations [5, 
10, 13, 18, 20, 22, 23, 26, 28, 29]: e.g., pregnancy, 
lactation, disruption of the hypophysial stalk, and 
organic lesions in the hypothalamus and hypophysial 
stalk. This stalk section effect is attributed to diminished 
synthesis, release, or adenohypophysial transport of 
dopamine, which is considered to be the main hypotha- 
lamic prolactin inhibiting factor. Hyperprolactinemia 
may be apparent in patients with primary long-standing 
hypothyroidism [3, 5, 13, 18, 21, 26, 28], Cushing's 
disease, and following treatment with several hormones 
and drugs such as estrogens and dopamine antagonists 
and in patients with liver cirrhosis presumably related to 
elevated estrogen levels associated with hepatic dys- 
function [9, 29]. Prolactin cell hyperplasia in primary 
hypothyroidism may result from excess TRH which 
stimulates prolactin cells with resultant hyperprolacti- 
nemia or from reduced hypothalamic dopamine, there- 
by facilitating prolactin secretion [21]. 
Prolactin cell hyperplasia is hardly ever the sole cause 
of pituitary disease. Scanlon et al. [20] described a 
patient with hyperprolactinemia/amenorrhea-galactor- 
rhea syndrome and an enlarged pituitary fossa who had a 
thyrotroph adenoma with surrounding lactotroph hyper- 
plasia. McKeel and Jacobs [15] noted diffuse prolactin 
cell hyperplasia in five hyperprolactinemic patients 
initially suspected of harboring discrete pituitary adeno- 
ma. Subsequently, they also reported prolactin cell 
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hyperplasia in 9/33 patients who underwent  transphenoi-  
dal surgery for hyperprolact inemia [16]. 
Adenohypophys ia l  cell hyperplasia as a cause of a 
clinical syndrome associated with pituitary hormone  
excess has been  recognized recently. Hyperplas ia  of G H  
cells has been  documented  in acromegalic patients and 
that  of cort icotrophs in association with Cushing's 
syndrome secondary to corticotropin (ACTH)-re leas ing 
hormone  producing tumors  [4, 14, 17, 19, 27]. In several 
patients with pituitary Cushing's disease the endocrine 
abnormali t ies  have been at tr ibuted to idiopathic corti- 
cotroph hyperplasia [24]. Thyro t roph  cell hyperplasia is 
known to occur in patients  with long-standing pr imary 
hypothyroidism [6]. Mice transgenic for growth hor- 
mone-releasing hormone  become giant and develop 
massive pituitary G H  cell hyperplasia [25]. These exam- 
ples clearly show that  diffuse hyperplasia should be  
regarded as a distinct pathological  entity. In some 
patients,  the hyperplasia  is pr imary  but the cause of cell 
proliferation remains obscure. 
In  the pat ient  presented here the causes resulting in 
hyperprolact inemia remain unresolved. The  pat ient  was 
not pregnant  and had no evidence of Cushing's disease, 
or of organic lesions in the hypothalamus-hypophysia l  
stalk area,  and was not t reated with hormones  and drugs 
which could account for the elevation of serum prolactin 
levels. Thus,  it is conceivable that  the diffuse prolactin 
cell hyperplasia was responsible for hyperprolact inemia.  
The  mechanism of this idiopathic prolactin cell hyper- 
plasia is not clear. While the serum TSH levels were 
above the normal  range and became normal  after oral 
thyroxine therapy, the serum prolactin levels remained 
unchanged.  Thus,  it may  be that  abnormal  receptors or 
some intracellular defects, or undisclosed prolactin- 
stimulating peptides or growth factors were responsible 
for the proliferation of prolactin cells and hyperprolac-  
t inemia. Further  studies are required to clarify the 
mechanisms of prolactin cell proliferation in this form of 
pituitary disease. 
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